UBS Group’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-1,300
| Closed | – | – | 7242 |
|
|
2016
Q3 | $0 | Sell |
1,300
-59,373
| -98% | – | ﹤0.01% | 7210 |
|
|
2016
Q2 | $28K | Buy |
60,673
+39,373
| +185% | +$18.2K | ﹤0.01% | 5158 |
|
|
2016
Q1 | $29K | Buy |
21,300
+10,331
| +94% | +$14.1K | ﹤0.01% | 5114 |
|
|
2015
Q4 | $16K | Buy |
10,969
+333
| +3% | +$486 | ﹤0.01% | 5750 |
|
|
2015
Q3 | $17K | Sell |
10,636
-14,067
| -57% | -$22.5K | ﹤0.01% | 5601 |
|
|
2015
Q2 | $42K | Buy |
24,703
+18,103
| +274% | +$30.8K | ﹤0.01% | 4904 |
|
|
2015
Q1 | $9K | Sell |
6,600
-51,576
| -89% | -$70.3K | ﹤0.01% | 5965 |
|
|
2014
Q4 | $88K | Buy |
+58,176
| New | +$88K | ﹤0.01% | 4316 |
|